We use some essential cookies to make this website work.
We’d like to set additional cookies to understand how you use GOV.UK, remember your settings and improve government services.
We also use cookies set by other sites to help us deliver content from their services.
You have accepted additional cookies. You can change your cookie settings at any time.
You have rejected additional cookies. You can change your cookie settings at any time.
Departments, agencies and public bodies
News stories, speeches, letters and notices
Detailed guidance, regulations and rules
Reports, analysis and official statistics
Consultations and strategy
Data, Freedom of Information releases and corporate reports
Anastrozole is now authorised as a preventative treatment for post-menopausal women at moderate or high risk of breast cancer.
Whether you’re a patient, healthcare professional or carer, this year’s #MedSafetyWeek campaign is calling on you to help improve the safety of medical products by reporting any suspected side effects and adverse incidents t…
Patients with a certain type of advanced or spreading non-small cell lung cancer (NSCLC) could access a new cancer therapy to help treat their condition.
Patients with severe alopecia areata (patchy hair loss) could access a new medicine to help treat their condition.
Over two million doses of illegally traded medicines valued at almost £5m seized so far this year.
New measures strengthen the safe use of the acne drug isotretinoin for patients across the UK, following a patient-focused expert review
The AI-Airlock will assist in the development and deployment of software and AI medical devices, safely providing patients with earlier access to cutting edge innovations that improve care.
Fake, potentially harmful Ozempic and Saxenda pens have been found in the UK: you should only access these medicines via a medical prescription.
The Medicines and Healthcare products Regulatory Agency (MHRA), US Food and Drug Administration (FDA) and Health Canada have collaborated to identify five guiding principles for the development of predetermined change contro…
Patients with recurring lymphoma, or who have not responded to prior treatments, could access a new bispecific antibody therapy to help treat their condition.
No evidence of supply or harm to patients
The scheme will see the lowest-risk clinical trials processed by the MHRA in less than 14 days.
Patients to receive the latest valproate safety information with every pack, following changes to the Human Medicines Regulations, 2012
Automation is the future for manufacturing stem cells, says the Head of the Medicines and Healthcare products Regulatory Agency’s UK Stem Cell Bank (UKSCB) on its 20th Anniversary.
Parents and carers should talk to their healthcare professional about how to feed colostrum (first milk) safely to their baby.
Almost three years on from the approval in the UK of the first COVID-19 vaccine, the Medicines and Healthcare products Regulatory Agency (MHRA) pays tribute to the scientists who developed the technology behind the mRNA COVI…
For the first time, patients with certain types of advanced or recurrent endometrial cancer could access a treatment shown to slow its progression
The Innovative Devices Access Pathway (IDAP) pilot was launched today by the Department of Health and Social Care (DHSC), Health Technology Wales (HTW), the Medicines and Healthcare products Regulatory Agency (MHRA), the Nat…
The vaccine was approved after it was found to meet the MHRA’s standards of safety, quality and effectiveness.
A new regional centre to promote Yellow Card reporting has been launched in Belfast today.
Don’t include personal or financial information like your National Insurance number or credit card details.
To help us improve GOV.UK, we’d like to know more about your visit today. Please fill in this survey.